Lv7
5000 积分 2021-10-17 加入
Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches
3个月前
已完结
Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
3个月前
已完结
Oncogenic role of nuclear accumulated Aurora‐A
3个月前
已完结
Aurora A kinase (AURKA) in normal and pathological cell division
3个月前
已完结
Target protein localization and its impact on PROTAC-mediated degradation
3个月前
已完结
Modeling of FAK-PROTAC candidates from GSK2256098 analogs for targeted protein degradation
3个月前
已完结
Biology of Aurora A kinase: Implications in cancer manifestation and therapy
3个月前
已完结
Development of Dual Aurora‐A and Aurora‐B Degrading PROTACs for MYCN‐Amplified Neuroblastoma
3个月前
已完结
Aurora Kinase A: Integrating Insights into Cancer, Inflammation, and Infectious Diseases
10个月前
已完结
Advances in the Design, Discovery, and optimization of aurora kinase inhibitors as anticancer agents
10个月前
已完结
皖公网安备34019202002308
